Inventor · disambiguated record
Kristy M. Wood
Also filed as: WOOD KRISTY M
18 granted patents·20 pending applications·1,425 citations·filing 2012–2023
97Inventor score
Top patents by PatentIndex Score
38 records- 0199US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0299US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0399US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0499US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0599US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0699US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 0799US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 0898US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 0998US8680069B2Modified polynucleotides for the production of G-CSFmodeRNA Therapeutics·Filed 2013·Granted Mar 25, 2014·180 cites·16 claims
- 1098US8664194B2Method for producing a protein of interest in a primatemodeRNA Therapeutics·Filed 2013·Granted Mar 4, 2014·90 cites·11 claims
- 1197US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 1297US9295689B2Formulation and delivery of PLGA microspheresMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 29, 2016·98 cites·9 claims
- 1397US8754062B2DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotidesmodeRNA Therapeutics·Filed 2013·Granted Jun 17, 2014·204 cites·7 claims
- 1496US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 1595US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 1692US9271996B2Formulation and delivery of PLGA microspheresMODERNA THERAPEUTICS INC·Filed 2013·Granted Mar 1, 2016·12 cites·9 claims
- 1791US10258698B2Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2014·Granted Apr 16, 2019·12 cites·6 claims
- 1891US9828416B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2015·Granted Nov 28, 2017·3 cites·24 claims
- 1987US2024123035A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2023·Application pending·0 cites
- 2081US2021115101A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 2179US2021299278A1Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2020·Application pending·0 cites
- 2272US2018086807A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2017·Application pending·0 cites
- 2372US2020164038A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2019·Application pending·0 cites
- 2471US2019240351A1Modified polynucleotides for the production of proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 2571US2024124897A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2669US2018170990A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 2767US2018125937A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2017·Application pending·0 cites
- 2867US2017028085A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2016·Application pending·0 cites
- 2966US2013266640A1Modified nucleoside, nucleotide, and nucleic acid compositionsmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 3066US2013245107A1Dlin-mc3-dma lipid nanoparticle delivery of modified polynucleotidesmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 3164US2013156849A1Modified nucleoside, nucleotide, and nucleic acid compositionsmodeRNA Therapeutics·Filed 2012·Application pending·0 cites
- 3263US2016193299A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3362US2023044994A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3458US2019142971A1Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2018·Application pending·0 cites
- 3556US2022273555A1Modified polynucleotides for the production of membrane proteinsMODERNATX INC·Filed 2020·Application pending·0 cites
- 3655US2023035659A1Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use ThereofINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3742US2016289674A1Modified polynucleotides for the production of membrane proteinsMODERNA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3835US2023140670A1FormulationsINTELLIA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kristy M. Wood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →